Tricyclic 2-Aminopyridinium Derivatives with Aggregation-Induced Emission for Concomitant Bacterial Discrimination and Inhibition

14 September 2020, Version 1
This content is a preprint and has not undergone peer review at the time of posting.

Abstract

The development of new ionic compounds with aggregation-induced emission (AIE) has been widely noticed. They can not only effectively solve the problem of aggregation-caused quenching (ACQ) encountered in conventional fluorescent dyes, but also exhibit promising applications in biological imaging, diagnosis and therapy, etc. However, such AIE system should be further developed. In this work, a series of novel cationic AIE luminogens (AIEgens) of tricyclic 2-aminopyridinium derivatives with seven-membered rings were designed and synthesized via a simple multi-component reaction, which exhibit the ability to specifically stain gram-positive bacteria. Meanwhile, they also possess excellent bacteriostatic ability for S. aureus in liquid medium and solid agar plates, of which the minimum inhibitory concentration (MIC) value is between 4 and 8 µg/mL. In addition, these molecules showed mitochondria-targeting capability in hydrophilic AIEgens and specific staining lysosomes in lipophilic AIEgens by wash-free process in living cells. These AIEgens with bacteriostatic activity hold great promise for distinguishing bacteria and inhibiting bacterial infection in clinical trial.

Keywords

Aggregation-induced emission
Tricyclic 2-Aminopyridinium Derivatives
Bacterial Discrimination
Bacterial inhibition

Supplementary materials

Title
Description
Actions
Title
Manuscript
Description
Actions
Title
Supporting information
Description
Actions

Comments

Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.